Yun Zhang - Xin Xiang Medical University

基本信息

浏览量：141

职业迁徙

个人简介

Yun Zhang currently works at the School of laboratory medicine, Xin Xiang Medical University. Yun does research in Biotechnology and Analytical Chemistry.

研究兴趣

论文共 52 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Rapid and Sensitive Detection of SARS-CoV-2 IgM Through Luciferase Luminescence on an Automatic Platform

Yibing Zhang,Yun Zhang,Wenhao Zhou,Ping He,Xueni Sun,Junhua Li,Hongping Wei,Junping Yu

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2024)

引用0浏览0WOS引用

Self-adjuvant Astragalus Polysaccharide-Based Nanovaccines for Enhanced Tumor Immunotherapy: a Novel Delivery System Candidate for Tumor Vaccines

Nan Li,Yun Zhang,Miaomiao Han,Tian Liu,Jinjia Wu,Yingxia Xiong, Yikai Fan,Fan Ye, Bing Jin,Yinghua Zhang,Guibo Sun,Xiaobo Sun,Zhengqi Dong

SCIENCE CHINA-LIFE SCIENCESno. 4 (2024): 680-697

引用0浏览0WOS引用

Green Synthesis of Carbon Dots from Fish Scales for Selective Turn Off-on Detection of Glutathione

Yi Zhang, Chunyu Lei, Ping Dong, Peiyang Fu,Yun Zhang,Ruifang Hua

RSC ADVANCESno. 5 (2024): 3578-3587

引用0浏览0WOS引用

Abstract CT053: Exploration of potential biomarkers correlated with efficacy of ociperlimab (anti-TIGIT) plus tislelizumab (anti-PD-1) in 1L PD-L1+ non-small cell lung cancer (NSCLC)

Se Hyun Kim, Jiayuan Zhang,Wei Tan, Han Yan, Tian Tian, Hao Zheng, Ziqi Zhou, Ruihua Wang,Yun Zhang,Zhirong Shen,Hye Ryun Kim,Diansheng Zhong,Shun Lu

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

侧流层析技术在大肠杆菌O157∶H7检测中的应用

田歌, 蒋亦佳,张赟

Chinese Journal of Food Hygiene（2024）

引用0浏览0引用

Longitudinal Ctdna Levels and Clinical Outcomes of First-Line (1L) Tislelizumab (TIS) Plus Chemotherapy (chemo) Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) in the RATIONALE-304 and 307 Studies

Shun Lu,Jie Wang,Meili Sun,Jun Zhao,Chunhong Hu,Mengzhao Wang,Jianying Zhou,Yong Song,Qinghua Zhou, Jiayuan Zhang,Yang Shi,Ruiqi Huang,Xikun Wu, Wanyu He, Xiaofei Qu,Yun Zhang,Zhirong Shen,Yan Yu

CANCER RESEARCHno. 8 (2023)

引用0浏览0引用

Supplementary Data from Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis

crossref（2023）

引用0浏览0引用

Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors

Dingwei Ye,Jayesh Desai,Jingwen Shi,Si-Yang Maggie Liu,Wei Shen,Tengfei Liu, Yang Shi,Dan Wang,Liang Liang,Silu Yang,Xiaopeng Ma,Wei Jin,Pei Zhang,Ruiqi Huang,Zhirong Shen,Yun Zhang,Yi-Long Wu

Biomark Res（2023）

引用5浏览0WOS引用

Association of Tumor Mutational Burden (TMB) and Clinical Outcomes with Tislelizumab Versus Chemotherapy in Esophageal Cell Carcinoma (ESCC) from RATIONALE-302

Lin Shen,Yongqian Shu,Kuaile Zhao,Taroh Satoh,Zhendong Chen,Eric Van Cutsem,Guohua Yu,Jun Wu,Chih-Hung Hsu,Sung Bae Kim, Wenting Du,Yang Shi,Ruiqi Huang,Qiao Li,Jingwen Shi,Yun Zhang,Kato Ken

CANCER RESEARCHno. 8 (2023)

引用0浏览0引用

Abstract LB289: Longitudinal Ctdna Levels and Clinical Outcomes of First-Line (1L) Tislelizumab (TIS) + Chemotherapy (chemo) Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) in the RATIONALE-304 and 307 Studies

Shun Lu,Jie Wang,Meili Sun,Jun Zhao,Chunhong Hu,Mengzhao Wang,Jianying Zhou, Yong Song,Qinghua Zhou,Jiayuan Zhang,Shiwen Yang,Ruiqi Huang,Xikun Wu, Weiji He, Xiaofei Qu,Yun Zhang,Zhirong Shen,Yan Yu

Cancer researchno. 8_Supplement (2023): LB289-LB289

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn